{"entity":{"type":"insider","cik":"0001844296","url":"/insider/0001844296","json_url":"/insider/0001844296.json","name":"Xontogeny, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":2,"first":"2021-02-08","last":"2021-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Xontogeny, LLC","source":"filing","n_filings":2,"first_seen":"2021-02-08","last_seen":"2021-02-09"}],"transactions":[{"id":4126229,"accession":"0001062993-21-001115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":99681.0,"shares_display":"99,681","price_per_share":14.080502803944583,"price_display":"14.08","price_state":"stated","total_value":1403558.6,"total_display":"1,403,558.60","total_whole":"1,403,559","shares_owned_after":7264800.0,"shares_owned_after_display":"7,264,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider","n_lines":2},{"id":4209218,"accession":"0001062993-21-001012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-21-001012","line_url":"/filing/0001062993-21-001012#line-6","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"Perceptive Xontogeny Venture Fund, LP; EDELMAN JOSEPH; Xontogeny, LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; PERCEPTIVE ADVISORS LLC","owner_display_name":"Perceptive Xontogeny Venture Fund, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":20000000.0,"total_display":"20,000,000.00","total_whole":"20,000,000","shares_owned_after":7049564.0,"shares_owned_after_display":"7,049,564","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-08","scope":"insider"},{"id":4126224,"accession":"0001062993-21-001115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":123053.0,"shares_display":"123,053","price_per_share":12.21474413464117,"price_display":"12.21","price_state":"stated","total_value":1503060.91,"total_display":"1,503,060.91","total_whole":"1,503,061","shares_owned_after":7198299.0,"shares_owned_after_display":"7,198,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4126203,"accession":"0001062993-21-001115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-21-001115","line_url":"/filing/0001062993-21-001115#line-1","is_derivative":false,"issuer_cik":"0001164426","issuer_name":"Landos Biopharma, Inc.","issuer_ticker":"LABP","issuer_name_source":null,"issuer_url":"/issuer/0001164426","owner_cik":null,"owner_name":"EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD; Perceptive Xontogeny Venture Fund, LP; Xontogeny, LLC; PERCEPTIVE ADVISORS LLC","owner_display_name":"EDELMAN JOSEPH","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27453.0,"shares_display":"27,453","price_per_share":11.14,"price_display":"11.14","price_state":"stated","total_value":305826.42,"total_display":"305,826.42","total_whole":"305,826","shares_owned_after":7077017.0,"shares_owned_after_display":"7,077,017","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001785345","name":"Landos Biopharma, Inc.","url":"/issuer/0001785345","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2021-02-08","last_seen":"2021-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001844296","retrieved_at":"2026-08-25T16:24:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}